Cisatracurium Besylate 00143-9397-10
- Manufacturer
- Hikma Pharmaceuticals Usa Inc.
- Dosage Form
- Injection
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- March 17, 2025
- Listing Expires
- December 31, 2026
- Application
- ANDA203079
Need to source Cisatracurium Besylate? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Cisatracurium Besylate | 2 mg/mL |
Drug Class
Neuromuscular Nondepolarizing Blockade [PE]Nondepolarizing Neuromuscular Blocker [EPC]
Selected Package
00143-9397-10Selected10 VIAL in 1 CARTON (0143-9397-10) / 10 mL in 1 VIAL (0143-9397-01)